Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1981 Feb;40(1):55–59. doi: 10.1136/ard.40.1.55

Protease inhibitors in inflammatory synovial effusions.

N M Hadler, A M Johnson, J K Spitznagel, R J Quinet
PMCID: PMC1000656  PMID: 7469525

Abstract

Granulocyte lysosomal enzymes can potentially participate in cartilage degradation in inflammatory arthritides. However, we have shown that the quantity of several such enzymes in an inflammatory synovial effusion correlates negatively with the degree of radiographic damage of the joint from which the fluid was sampled. In the current work the quantity of the following 5 protease inhibitors was determined immunochemically in the same fluids: alpha 1 antitrypsin, alpha 1-antichymotrypsin, alpha 2-macroglobulin, inter-alpha-trypsin inhibitor, and Cl esterase inhibitor. These inhibitors are generally covariate and correlate positively with the total protein in the fluid as well as the number of granulocytes and the concentration of granulocyte lysosomal enzymes in the fluid. As did the lysosomal enzymes, the protease inhibitors correlate negatively with radiographic destruction. It is likely that lysosomal enzymes in solution in inflammatory synovial effusions are rendered effete by the presence of protease inhibitors.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooke T. D., Hurd E. R., Jasin H. E., Bienenstock J., Ziff M. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum. 1975 Nov-Dec;18(6):541–551. doi: 10.1002/art.1780180603. [DOI] [PubMed] [Google Scholar]
  2. Dingle J. T. Articular damage in arthritis and its control. Ann Intern Med. 1978 Jun;88(6):821–826. doi: 10.7326/0003-4819-88-6-821. [DOI] [PubMed] [Google Scholar]
  3. Freiman J. A., Chalmers T. C., Smith H., Jr, Kuebler R. R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978 Sep 28;299(13):690–694. doi: 10.1056/NEJM197809282991304. [DOI] [PubMed] [Google Scholar]
  4. HAVERBACK B. J., DYCE B., BUNDY H. F., WIRTSCHAFTER S. K., EDMONDSON H. A. Protein binding of pancreatic proteolytic enzymes. J Clin Invest. 1962 May;41:972–980. doi: 10.1172/JCI104576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hadler N. M. A pathogenetic model for erosive synovitis: lessons from animal arthritides. Arthritis Rheum. 1976 Mar-Apr;19(2):256–266. doi: 10.1002/art.1780190222. [DOI] [PubMed] [Google Scholar]
  6. Hadler N. M., Spitznagel J. K., Quinet R. J. Lysosomal enzymes in inflammatory synovial effusions. J Immunol. 1979 Aug;123(2):572–577. [PubMed] [Google Scholar]
  7. Howell D. S., Sapolsky A. I., Pita J. C., Woessner J. F. The pathogenesis of osteoarthritis. Semin Arthritis Rheum. 1976 May;4(4):365–383. doi: 10.1016/0049-0172(76)90015-9. [DOI] [PubMed] [Google Scholar]
  8. James H. L., Cohen A. B. Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin. J Clin Invest. 1978 Dec;62(6):1344–1353. doi: 10.1172/JCI109255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Janoff A., Feinstein G., Malemud C. J., Elias J. M. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue. J Clin Invest. 1976 Mar;57(3):615–624. doi: 10.1172/JCI108317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Keiser H., Greenwald R. A., Feinstein G., Janoff A. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. II. Degradation of isolated bovine nasal cartilage proteoglycan. J Clin Invest. 1976 Mar;57(3):625–632. doi: 10.1172/JCI108318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Killingsworth L. M., Buffone G. J., Sonawane M. B., Lunsford G. C. Optimizing nephelometric measurement of specific serum proteins: evaluation of three diluents. Clin Chem. 1974 Dec;20(12):1548–1552. [PubMed] [Google Scholar]
  12. Kushner I., Somerville J. A. Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum. 1971 Sep-Oct;14(5):560–570. doi: 10.1002/art.1780140503. [DOI] [PubMed] [Google Scholar]
  13. Leffell M. S., Spitznagel J. K. Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes. Infect Immun. 1972 Nov;6(5):761–765. doi: 10.1128/iai.6.5.761-765.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Malemud C. J., Janoff A. Human polymorphonuclear leukocyte elastase and cathepsin G mediate the degradation of lapine articular cartilage proteoglycan. Ann N Y Acad Sci. 1975 Jun 13;256:254–262. doi: 10.1111/j.1749-6632.1975.tb36051.x. [DOI] [PubMed] [Google Scholar]
  15. Morse J. O. Alpha1-antitrypsin deficiency (second of two parts). N Engl J Med. 1978 Nov 16;299(20):1099–1105. doi: 10.1056/NEJM197811162992003. [DOI] [PubMed] [Google Scholar]
  16. Ohlsson K., Olsson I., Spitznagel K. Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe Seylers Z Physiol Chem. 1977 Mar;358(3):361–366. doi: 10.1515/bchm2.1977.358.1.361. [DOI] [PubMed] [Google Scholar]
  17. Oronsky A. L., Perper R. J. Connective tissue-degrading enzymes of human leukocytes. Ann N Y Acad Sci. 1975 Jun 13;256:233–253. doi: 10.1111/j.1749-6632.1975.tb36050.x. [DOI] [PubMed] [Google Scholar]
  18. Shope R. E. An antiviral substance from Penicillium funiculosum. VII. An attempt to determine whether the material responsible for the antipassive immunity effect exhibited by mice injected with helenine is an interferon. J Exp Med. 1966 Nov 1;124(5):915–919. doi: 10.1084/jem.124.5.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Spilberg I. Current concepts of the mechanism of acute inflammation in gouty arthritis. Arthritis Rheum. 1975 Mar-Apr;18(2):129–134. doi: 10.1002/art.1780180208. [DOI] [PubMed] [Google Scholar]
  20. Spitznagel J. K., Dalldorf F. G., Leffell M. S., Folds J. D., Welsh I. R., Cooney M. H., Martin L. E. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest. 1974 Jun;30(6):774–785. [PubMed] [Google Scholar]
  21. Starkey P. M., Barrett A. J., Burleigh M. C. The degradation of articular collagen by neutrophil proteinases. Biochim Biophys Acta. 1977 Aug 11;483(2):386–397. doi: 10.1016/0005-2744(77)90066-3. [DOI] [PubMed] [Google Scholar]
  22. Starkey P. M., Barrett A. J. Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastase and cathepsin G. Biochem J. 1976 May 1;155(2):255–263. doi: 10.1042/bj1550255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ugai K., Ziff M., Jasin H. E. Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues. Arthritis Rheum. 1979 Apr;22(4):353–364. doi: 10.1002/art.1780220407. [DOI] [PubMed] [Google Scholar]
  24. Zvaifler N. J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16(0):265–336. doi: 10.1016/s0065-2776(08)60299-0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES